Categories Earnings, LATEST, Other Industries

Medtronic to acquire Mazor for $1.64 billion

Medtronic plc (MDT) has agreed to buy Mazor Robotics for $1.64 billion. The all-cash deal, which amounts to $29.25 per ordinary share, is expected to close in Q3 2019. The deal has been approved by the boards of both companies and is subject to approval from shareholders and regulatory agencies.

medtronic acquires mazor
(Image Courtesy: Marcel Scholte/Unsplash)

Medtronic expects the deal to be modestly dilutive to fiscal year 2019 adjusted EPS and to generate a double-digit return on invested capital by year four, with an increasing contribution thereafter. Medtronic and Mazor have been partners for the past two years with the former holding an existing 11% stake in Mazor.

Mazor manufactures robotic-assisted guidance systems for surgeries and the company’s Mazor X and Renaissance systems are being used in several countries worldwide. Medtronic expects Mazor’s guidance systems to be a significant addition to its portfolio of products and hopes the deal will open up new opportunities in the surgical space.

Last month Medtronic reported first quarter results that topped analyst expectations. The company saw its highest revenue growth in emerging markets and non-US markets while revenues in the US dropped 4% year-over-year. The company also raised its sales outlook for the full year of 2019.

Medtronic stock is up 20% thus far this year and looking at the past three months, the stock is up 12%. The stock was trading down slightly at $97.20 as of 1:35 pm ET.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top